US Patent 11583581 Methods of treating a retroviral infection

Patent 11583581 was granted and assigned to Gilead Sciences on February, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Gilead Sciences

Current Assignee

Gilead Sciences

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

115835810

Date of Patent

February 21, 2023

Patent Application Number

157604240

Date Filed

September 21, 2016

Patent Citations

‌

US Patent 10487333 Combination comprising immunostimulatory oligonucleotides

‌

US Patent 10006032 Predictive biomarker for cancer therapy

‌

US Patent 10604760 Combination comprising immunostimulatory oligonucleotides

Patent Primary Examiner

‌

Nicole Kinsey White

The invention relates to a non-coding sequence of deoxyribonucleic acids comprising at least one sequence motif N

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11583581 Methods of treating a retroviral infection

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API